Investor's Digest of Canada •2020-08-27 •
A manufacturer of higher-value, higher-margin edible, vape and beverage products and a provider of incision-free therapies for the treatment of prostate cancer are “strong buys”.
Before this year’s stock market correction, Read More
Investor's Digest of Canada •2020-07-23 •
A manufacturer of higher-value, higher-margin edible, vape and beverage products and a provider of incision-free therapies for the treatment of prostate cancer are “strong buys”.
Before this year’s stock market correction, Read More
The MoneyLetter •2019-09-26 •
A recent survey by The MoneyLetter of securities analysts’ reports found two junior cannabis-related stocks favored by Toronto-based Mackie Research Capital.
Toronto-based Mackie Research analyst Nikhil Thadani initiated coverage of technology Read More
The MoneyLetter •2018-04-04 •
A number of established medical marijuana producers are preparing themselves for expansion and entry into the soon-to-be-legal recreational marijuana market. The MoneyLetter recently surveyed a number of security analysts’ reports Read More
Investor's Digest of Canada •2017-04-24 •
Healthcare stock Emblem Corp. is a Canadian licensed producer of medical marijuana, providing patients with high-quality, premium cannabis strains. It has recently sourced a supply of high-cannabidiol marijuana from a Read More
